Bill C A, Yu Y, Miselis N R, Little J B, Nickoloff J A
Department of Cancer Biology, Harvard University School of Public Health, Boston, MA 02115, USA.
Mutat Res. 1997 Oct;385(1):21-9. doi: 10.1016/s0921-8777(97)00040-2.
The tumor suppressor p53 is a major regulator in the response of human cells to DNA damage. In this study we assessed the role of p53 in the repair of DNA double-strand breaks in plasmid DNA using cell extracts from three human lymphoblastoid cell lines derived from the same donor. TK6, WI-L2-NS and TK6-E6-5e cells express wild-type, mutated and essentially no p53 protein, respectively. Total cellular extracts from TK6, WI-L2-NS and TK6-E6-5e cells were incubated with EcoRI linearized pUC19 DNA. Southern blot analysis of end-rejoined DNA indicated that the major products formed were linear multimers. There was approximately 2-fold greater end rejoining in WI-L2-NS and TK6-E6-5e extracts compared with TK6 extracts. Total DNA from end-rejoining reactions was purified and used to transform bacteria. Using the lacZ reporter gene as a measure of repair fidelity we found that misrepair, as indicated by white colonies, occurred at 4.1% to 6.5% of transformants, with no significant difference between the three cell lines. Gel analysis revealed that misrepair involved only deletions. Sequence analysis of 11 misrepaired products from each cell line showed 12 different deletions from 4 to 48 bp in length, but each cell line yielded similar product types. These results indicate that total cellular extracts from human lymphoblastoid cells lacking p53 or expressing mutated p53 have increased end-rejoining activity as compared with extracts from cells expressing wild-type p53. However, the p53 status does not influence the ratio of misrepair:correct repair, or the type of misrepair events.
肿瘤抑制因子p53是人类细胞对DNA损伤作出反应的主要调节因子。在本研究中,我们使用来自同一供体的三个人类淋巴母细胞系的细胞提取物,评估了p53在质粒DNA双链断裂修复中的作用。TK6、WI-L2-NS和TK6-E6-5e细胞分别表达野生型、突变型和基本不表达p53蛋白。将TK6、WI-L2-NS和TK6-E6-5e细胞的总细胞提取物与EcoRI线性化的pUC19 DNA一起孵育。对末端重新连接的DNA进行Southern印迹分析表明,形成的主要产物是线性多聚体。与TK6提取物相比,WI-L2-NS和TK6-E6-5e提取物中的末端重新连接大约多2倍。将末端重新连接反应的总DNA纯化并用于转化细菌。使用lacZ报告基因作为修复保真度的指标,我们发现白色菌落所示的错配修复发生在4.1%至6.5%的转化体中,三个细胞系之间没有显著差异。凝胶分析表明,错配修复仅涉及缺失。对每个细胞系的11个错配修复产物进行序列分析,结果显示有12种不同长度为4至48 bp的缺失,但每个细胞系产生的产物类型相似。这些结果表明,与表达野生型p53的细胞提取物相比,缺乏p53或表达突变型p53的人类淋巴母细胞的总细胞提取物具有更高的末端重新连接活性。然而,p53状态并不影响错配修复与正确修复的比例,也不影响错配修复事件的类型。